Mony Group PLC header image

Mony Group PLC

MONY

Equity

ISIN GB00B1ZBKY84 / Valor 3291862

LSE London Stock Exchange, SETS (2026-01-20)
GBP 1.83-1.18%

Mony Group PLC
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

I can't write an accurate one-paragraph description because the source you said you'd provide is missing; please paste the company's "About" text or a link to it. If you prefer, I can proceed using publicly available information about Mony Group PLC (or prepare a short general profile based on typical corporate structures) — tell me which and I will produce the one-paragraph description.

Summarized from source with an LLMView SourceSector: Technology

Latest Results (20.01.2026):

MONY Group PLC — reporting full-year results for the year ended 31 December 2024 (FY24) with commentary on Quarter 4 (Q4 2024). The group delivered record Adjusted EBITDA of £141.8m (+7%) on revenue of £439.2m (+2%), Profit After Tax of £80.2m (+11%) and Adjusted basic EPS of 17.1p (+5%). Operating cashflow improved to £115.6m (+13%), the balance sheet returned to net cash of £8.4m, the Board proposes a final dividend of 9.2p (total FY24 dividend 12.5p, +3%) and announced a share buyback programme of up to £30m. SuperSaveClub exceeded 1 million members and now generates c.12% of Group sales.

Financial headlines

FY24 revenue £439.2m (+2%); record Adjusted EBITDA £141.8m (+7%) with margin widening to c.32%; Profit After Tax £80.2m (+11%); basic EPS 15.0p (+11%), adjusted basic EPS 17.1p (+5%).

Cash, balance sheet & capital returns

Operating cashflow £115.6m (+13%); returned to net cash of £8.4m (vs £19.8m net debt in 2023) after repaying the Quidco term loan. Board proposes final dividend 9.2p (full year 12.5p, +3%) and a share buyback programme up to £30m funded from expected 2025 cash generation.

Q4 2024 trading snapshot

Quarter to 31 Dec 2024: total revenue £102.8m (flat). Insurance £53.0m (+2%) drove performance; Money £22.7m (-2%); Home Services £10.0m (0%); Travel £2.7m (-6%); Cashback £16.8m (0%). Group notes softer Money and Travel in Q4 offsetting Insurance strength.

Strategic progress — members and products

SuperSaveClub (launched Sept 2023) surpassed 1m members and now contributes ~12% of Group sales; SSC members show higher engagement, repeat purchases and ARPU. MSE app and Quidco enhancements and broader B2B, Tenancy and Market Boost roll‑outs supported growth and diversification.

Adjusting items, tax and costs

Adjusting items include a £3.0m provision for irrecoverable VAT and related costs (presented as adjusting items while discussions with HMRC continue) and amortisation of acquisition-related intangibles (£10.8m). Effective tax rate rose to 26.2% (2023: 21.5%), which reduced adjusted EPS growth vs EBITDA.

Outlook

The Board expects 2025 Adjusted EBITDA to be broadly within current published consensus (analyst consensus ~£147.0m, range £143.1m–£151.7m). Management cites resilience from breadth of offerings, ongoing cost-efficiency and continued SSC/member momentum despite headwinds in some insurance sub-markets.

Summarized from source with an LLMView Source

Key figures

-1.56%1Y
-13.9%3Y
-31.6%5Y

Performance

20.8%1Y
25.6%3Y
28.4%5Y

Volatility

Market cap

1327 M

Market cap (USD)

Daily traded volume (Shares)

415,411

Daily traded volume (Shares)

1 day high/low

1.916 / 1.901

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Regeneron Pharmaceuticals Inc
Regeneron Pharmaceuticals Inc Regeneron Pharmaceuticals Inc Valor: 965755
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.10%USD 733.78
INTERSHOP Communications AG
INTERSHOP Communications AG INTERSHOP Communications AG Valor: 52515678
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
6.30%EUR 1.35
artnet AG
artnet AG artnet AG Valor: 13664519
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%EUR 11.30
SEVEN PRINCIPLES AG
SEVEN PRINCIPLES AG SEVEN PRINCIPLES AG Valor: 30741641
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.64%EUR 4.80
NanoRepro AG
NanoRepro AG NanoRepro AG Valor: 4691951
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.19%EUR 1.56
beaconsmind Ltd
beaconsmind Ltd beaconsmind Ltd Valor: 45112358
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.82%EUR 5.60
Schweizer Electronic AG
Schweizer Electronic AG Schweizer Electronic AG Valor: 1218002
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.83%EUR 6.05
Bio-Gate AG
Bio-Gate AG Bio-Gate AG Valor: 20104373
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.50%EUR 0.78
Exelixis Inc
Exelixis Inc Exelixis Inc Valor: 1069927
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.41%USD 43.78
Mynaric AG
Mynaric AG Mynaric AG Valor: 121337525
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.00%EUR 0.17